Click and bioorthogonal chemistry: the future of active targeting of nanoparticles for nanomedicines?

L Taiariol, C Chaix, C Farre, E Moreau - Chemical Reviews, 2021 - ACS Publications
Over the years, click and bioorthogonal reactions have been the subject of considerable
research efforts. These high-performance chemical reactions have been developed to meet …

Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency

OM Kutova, EL Guryev, EA Sokolova, R Alzeibak… - Cancers, 2019 - mdpi.com
Malignant tumors are characterized by structural and molecular peculiarities providing a
possibility to directionally deliver antitumor drugs with minimal impact on healthy tissues and …

Recent advances in bioorthogonal click chemistry for enhanced PET and SPECT radiochemistry

X Zhong, J Yan, X Ding, C Su, Y Xu… - Bioconjugate …, 2023 - ACS Publications
Due to their high reaction rate and reliable selectivity, bioorthogonal click reactions have
been extensively investigated in numerous research fields, such as nanotechnology, drug …

The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease

JC Evans, M Malhotra, JF Cryan… - British journal of …, 2016 - Wiley Online Library
Prostate specific membrane antigen (PSMA) otherwise known as glutamate
carboxypeptidase II (GCPII) is a membrane bound protein that is highly expressed in …

Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery

PT Wong, SK Choi - International journal of molecular sciences, 2015 - mdpi.com
The rational design of a nanoplatform in drug delivery plays a crucial role in determining its
targeting specificity and efficacy in vivo. A conventional approach relies on the surface …

Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy

CF Wang, EM Mäkilä, MH Kaasalainen, MV Hagström… - Acta biomaterialia, 2015 - Elsevier
Dual-drug delivery of antiangiogenic and chemotherapeutic drugs can enhance the
therapeutic effect for cancer therapy. Conjugation of methotrexate (MTX) to porous silicon …

[HTML][HTML] Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy

F Hao, RJ Lee, L Zhong, S Dong, C Yang, L Teng… - Theranostics, 2019 - ncbi.nlm.nih.gov
Purpose: Methotrexate (MTX) is a first-line drug for rheumatoid arthritis (RA) therapy.
However, MTX monotherapy often results in irreversible joint damage due to its slow onset …

Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer

RP Johnson, CK Ratnacaram, L Kumar, J Jose - Drug Resistance Updates, 2022 - Elsevier
Prostate cancer (PC) is the most prevalent male urogenital cancer worldwide. PC patients
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …

Small-format drug conjugates: a viable alternative to ADCs for solid tumours?

MP Deonarain, G Yahioglu, I Stamati, A Pomowski… - Antibodies, 2018 - mdpi.com
Antibody–Drug Conjugates (ADCs) have been through multiple cycles of technological
innovation since the concept was first practically demonstrated~ 40 years ago. Current …

PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation

AE Machulkin, AA Uspenskaya, NY Zyk… - European Journal of …, 2022 - Elsevier
Prostate cancer is one of the most commonly diagnosed men's cancers and remains one of
the leading causes of cancer death. The development of approaches to the treatment of this …